Kips Bay Medical focuses on developing investigational devices aimed at improving the arterialization of saphenous veins, which are often used in coronary artery bypass grafting (CABG) procedures. The company operates within the medical device industry, specifically targeting cardiovascular health. Kips Bay Medical's primary clients include healthcare providers and medical researchers who are involved in clinical trials and surgical procedures. The company is currently in the investigational phase, meaning its devices are not yet commercially available and are limited by federal law to investigational use in the United States. Kips Bay Medical generates revenue through funding and grants aimed at advancing its clinical trials and research initiatives. The business model is centered around innovation in medical technology, with a focus on long-term clinical outcomes and regulatory approval.

Keywords: investigational devices, arterialization, saphenous veins, coronary artery bypass grafting, cardiovascular health, clinical trials, medical research, healthcare providers, surgical procedures, medical technology.